Antibiotics

Indicated for the treatment of pruritus associated with allergic dermatitis and the clinical manifestations of atopic dermatitis in dogs. Active ingredient: Oclacitinib Maleate

Pigs: For the treatment of bacterial enteritis caused by E. coli susceptible to apramycin. Calves: For the treatment of bacterial enteritis caused by E.coli and clinical outbreaks due to salmonella enterica serovar Dublin susceptible to apramycin. Chickens: For the treatment of colibacillosis caused by E.coli susceptible to apramycin.

Aquaprim is a broad spectrum antibacterial combination product containing two active substances: Trimethoprim 40mg/ml and Sulphadiazine 200 mg/ml. It is used for the treatment of disease caused by gram positive and gram negative micro-organisms sensitive to this combination. Species: Cattle and Pigs Dose: 12 ml per 100kg bodyweight daily for three consecutive days Calf 6.0 ml per 50 kg Cattle 12 ml per 100 kg Maximum volume at any one site of injection for cattle is 20 ml Piglet 0.6 ml per 5 kg Weaner 2.4 ml per 20 kg Fattner/Sow 9.0 ml per 75 kg Maximum volume at any one site of injection for a pig is 10ml Administration: For Intramuscular use only Withdrawal Meat and Offal: 25 days after last treatment. Milk: Not to be used for human consumption during treatment or for 72 hours (3 days) thereafter.

he ASERVO EQUIHALER is designed specifically for use in horses with severe equine asthma. An ergonomic handle and dosing lever make it simple to administer. The anatomically designed nostril adaptor fits inside the left nostril of the horse, making it easier for them to inhale the medicated mist.

Treatment of infections caused by strains sensitive to tetracycline and/or neomycin in calves. Active ingredient: Tetracycline, Neomycin

Contains enrofloxacin, a fluoroquinolone. Fluoroquinolones should be reserved for the treatment of clinical conditions which have responded poorly, or are expected to respond poorly to other classes of antimicrobials. Wherever possible, fluoroquinolones should only be used based on susceptibility testing. Cattle Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and secondary bacterial infections subsequent to viral infections (e.g. viral pneumonia) where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice. Treatment of local signs (inflammation, milk quality and yield) associated with peracute/acute mastitis in lactating dairy cattle caused by E. coli, where herd history and previous sensitivity testing indicate enrofloxacin as the drug of choice. Pigs Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis), and multifactorial diseases such as atrophic rhinitis and enzootic pneumonia, where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice. Dosage & Administration Cattle For respiratory and alimentary infections in cattle and secondary bacterial infections: administer by subcutaneous injection. 2.5 mg enrofloxacin per kg bodyweight daily by subcutaneous injection for 3 days (2.5 ml per 100 kg bodyweight) This rate may be doubled to 5 mg/kg bodyweight (5 ml per 100 kg) for 5 days for salmonellosis and complicated respiratory disease. Not more than 10 ml should be administered at any one subcutaneous injection site. For E. coli mastitis: administer by slow intravenous injection. 5.0 ml per 100 kg bodyweight (5 mg enrofloxacin per kg bodyweight) daily for 2 days. Pigs For respiratory and alimentary infections in pigs and secondary bacterial infections: administer by intramuscular injection. 2.5 mg enrofloxacin per kg bodyweight daily by intramuscular injection for 3 days (2.5 ml per 100 kg bodyweight). This rate may be doubled to 5 mg/kg bodyweight (5 ml per 100 kg) for 5 days for salmonellosis and complicated respiratory disease. Not more than 2.5 ml should be administered at any one intramuscular injection site in store pigs or 5 ml at any one intramuscular injection site in sows. Withdrawals Cattle: Subcutaneous Use Meat and Offal: 10 days Milk: 84 hours (7 milkings) Intravenous Use Meat and Offal: 4 days Milk: 72 hours (6 milkings) Pigs: Intramuscular Use: Meat and Offal: 10 days

Baytril 2.5% Oral Solution is for use in calves for the treatment of infections of the alimentary and respiratory tracts of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis and salmonellosis), where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice. Baytril 2.5% Oral Solution may also be used in exotic animals (small mammals, reptiles and avian species) for the treatment of bacterial infections of the alimentary and respiratory tracts where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice. Active ingredient: Enrofloxacin

Dogs and Cats Treatment of bacterial infections of the alimentary, respiratory and urogenital tracts, skin, secondary wound infections and otitis externa where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice. Cattle Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and secondary bacterial infections subsequent to viral conditions (e.g. viral pneumonia) where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice. Pigs Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, actinobacillosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and mulifactorial diseases such as atrophic rhinitis and enzootic pneumonia, where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice. Active ingredient: Enrofloxacin

Cattle For the treatment of respiratory tract infections caused by enrofloxacin-sensitive Histophilus somni, Mannheimia haemolytica, Pasteurella multocida and Mycoplasma spp. For the treatment of Mastitis caused by enrofloxacin-sensitive E. coli. Pigs For the treatment of bacterial bronchopneumonia caused by enrofloxacin-sensitive Actinobacillus pleuropneumoniae, Pasteurella multocida and complicated by Haemophilus parasuis as secondary pathogen in pigs. VPA 10021/065/001. Active ingredient: Enrofloxacin

The product is for use in dogs and cats in the treatment of bacterial infections of the alimentary, respiratory and urogenital tracts, skin, secondary wound infections and otitis externa where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice. Active ingredient: Enrofloxacin

Suitable for the control of infections, due to susceptible micro-organisms, in cattle, sheep, pigs, dogs and cats where a single injection giving prolonged activity is required. It may also protect from secondary bacterial invasion in cases where bacteria are not the initial cause of disease. Indications include infections of: Alimentary tract, Respiratory tract, Skin and soft tissue, Urogenital tract, In prevention of post-operative infection (treat before surgery). Active ingredient: Amoxicillin

Is a broad spectrum semi-synthetic penicillin, bactericidal in action for use in cattle, sheep, pigs, dogs and cats. In vitro it is effective against a wide range of Gram-positive and Gram-negative pathogenic bacteria. Active ingredient: Amoxicillin